Skip to content

Clinical trials

Phase 1/2 trials in Norway with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Unknown status Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20081
20101
20131
20161
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital3
Ullevaal University Hospital2
Karolinska University Hospital1
Kringle Pharma Europe AB1
Nordic Lymphoma Group1
University of Aarhus1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conversion Disorder1
Esophageal Neoplasms1
Hyperglycemia1
Leukemia, Myeloid, Acute1
Lymphoma1
Lymphoma, Non-Hodgkin1
Prostatic Neoplasms1
Recurrence1
Stroke1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.